| 000 | 00941 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250511190249.0 | ||
| 264 | 0 | _c19920914 | |
| 008 | 199209s 0 0 eng d | ||
| 022 | _a0362-5664 | ||
| 024 | 7 |
_a10.1097/00002826-199201001-00249 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMayer, D J | |
| 245 | 0 | 0 |
_aCholecystokinin and opiate interactions. _h[electronic resource] |
| 260 |
_bClinical neuropharmacology _c1992 |
||
| 300 |
_a477A-478A p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCholecystokinin _xpharmacology |
| 650 | 0 | 4 |
_aEndorphins _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNarcotics _xpharmacology |
| 700 | 1 | _aKellstein, D E | |
| 773 | 0 |
_tClinical neuropharmacology _gvol. 15 Suppl 1 Pt A _gp. 477A-478A |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002826-199201001-00249 _zAvailable from publisher's website |
| 999 |
_c1505402 _d1505402 |
||